USA Today reports that the FDA has worked out a deal to make up for ongoing doxil shortage by importing a replacement drug, Lipodox, from India. The manufacturer, Sun Pharma Global, has already passed FDA inspecting and exports drugs to numerous countries. The article also reports that an anticipated shortage of methotrexate has been averted, with other pharmaceutical companies ramping up production of the drug.